1. Home
  2. Press release
Apr 25, 2019 15:13 JST

Source: NEC Corporation

Biomedical Software Startup BostonGene Secures $50M in Series A Financing from NEC
- Proceeds to Support Scaling and Advancement of Precision Medicine Computing Platform for Cancer Treatment -

TOKYO, Apr 25, 2019 - (JCN Newswire) - NEC Corporation (TSE: 6701) and BostonGene Corporation (BostonGene), a Boston, Mass-based biomedical software company, has announced a $50M series A strategic investment in BostonGene by NEC.

BostonGene, a pioneer in the use of biomedical software for advanced patient analysis, has discovered, developed, and patented a holistic approach to cancer treatment by defining the optimal therapy combination for individual patients, with a particular focus on immuno- and targeted therapies.

BostonGene's solution includes:

Genome and transcriptome sequencing methods to create a patient's molecular profile.
Algorithms that estimate the immune fitness and cancer characteristics of a patient.
A continuously updated expert-curated and Artificial Intelligence (AI)-driven database of cancer research and clinical information.

Cloud-native software that delivers a patient-prioritized list of best treatment options based on comprehensive data analysis of the tumor and its microenvironment.

Founded in 2015, BostonGene has evaluated its solution utilizing extensive data in close collaboration with many leading cancer centers across the U.S., and has a robust intellectual property portfolio.

The funding will allow BostonGene to accelerate its long-term strategy, enable the expansion of the company's development efforts, advance its collaboration programs, and support the growth of its talented and diverse team.

"As demonstrated by its remarkable growth and early widespread adoption, BostonGene is leading the precision medicine market in the innovation and development of a mission-critical computing platform," said Osamu Fujikawa, senior vice president and head of the Business Innovation Unit at NEC Corporation. "NEC and BostonGene share a common vision of the immense potential of an AI-driven approach to cancer immunotherapy. Leveraging the strengths of both companies we will be able to improve the survival rate and quality of life for cancer patients."

"Transforming and personalizing medicine, from treating a diagnosis to treating the person, is becoming a reality with BostonGene's unique breakthrough platform. Our early successes validate the market need and the potential of our solution to truly transform cancer treatment and dramatically improve patients' chances for survival and quality of life. An investment of this magnitude will support our vision, mission and strategy, as well as the formation of synergies with the NEC Health Tech business to create meaningful new opportunities," said Andrew Feinberg, President and CEO of BostonGene.

About BostonGene Corporation

BostonGene Corporation is pioneering the use of biomedical software for advanced patient analysis and personalized therapy decision making in the fight against cancer. BostonGene's unique solution performs sophisticated analytics to aid clinicians in their evaluation of viable treatment options for each patient's individual genetics, tumor and tumor microenvironment, clinical characteristics and disease profile. BostonGene's mission is to enable physicians to provide every patient with the highest probability of survival through optimal cancer treatments using advanced, personalized therapies. For more information, visit BostonGene at http://www.BostonGene.com.

Contact:
NEC
Seiichiro Toda        
s-toda@cj.jp.nec.com
+81-3-3798-6511
Source: NEC Corporation
Sectors: Cloud & Enterprise, BioTech

Copyright ©2024 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.

Related Press Release

NEC Develops High-speed Generative AI Large Language Models (LLM) with World-class Performance
April 24 2024 12:25 JST
 
NEC Strengthens Commitment to Space Industry with Investment in Seraphim Space Venture Fund II
April 22 2024 14:09 JST
 
DOCOMO, NTT, NEC and Fujitsu Develop Top-level Sub-terahertz 6G Device Capable of Ultra-high-speed 100 Gbps Transmission
April 11 2024 14:10 JST
 
Transgene and NEC Present First Clinical Benefits of Neoantigen Cancer Vaccine, TG4050, in Head & Neck Cancer at AACR 2024
April 10 2024 12:36 JST
 
NEC white paper proposes comprehensive process workflow for the application of AI-driven personalized cancer vaccines
April 08 2024 12:45 JST
 
NEC develops marketing strategy planning & effectiveness simulation technology using generative AI
March 25 2024 09:08 JST
 
NEC and NTT successfully conduct first-of-its-kind long-distance transmission experiment over 7,000km using 12-core optical fiber
March 22 2024 07:38 JST
 
NEC and Tokyo Medical and Dental University use AI to assist self-care for chronic lower back pain
March 21 2024 09:02 JST
 
NEC and Skyloom to Pioneer 100 Gbps Space Optical Communications, Transforming Global Internet Connectivity
March 20 2024 14:30 JST
 
NEC named to list of Top 100 Global Innovators by Clarivate for 13th consecutive year
March 07 2024 10:24 JST
 
More Press release >>

Latest Press Release


Mazda Production and Sales Results for March 2024 and for April 2023 through March 2024
Apr 25, 2024 18:21 JST

MHI Begins Operation of SOEC Test Module the Next-Generation High-Efficiency Hydrogen Production Technology at Takasago Hydrogen Park
Apr 25, 2024 17:45 JST

GAC Honda to Begin Sales of All-new e:NP2, the Second Model of e:N Series
Apr 25, 2024 16:50 JST

Toyota Exhibiting at Beijing Motor Show 2024
Apr 25, 2024 16:25 JST

Honda Reaches Basic Agreement with Asahi Kasei on Collaboration for Production of Battery Separators for Automotive Batteries in Canada
Apr 25, 2024 11:10 JST

UNIQLO Sponsors KAWS + Warhol Exhibition Tour, Starting in Pittsburgh
Apr 25, 2024 09:00 JST

Mitsubishi Power Begins Commercial Operation of Seventh M701JAC Gas Turbine in Thailand GTCC Project; Achieves 75,000 AOH To-Date
Apr 24, 2024 17:19 JST

MC and Denka Sign J/V Agreement in Fullerene Business
Apr 24, 2024 17:02 JST

Mitsubishi Motors Posts Record Sales in the Philippines in FY2023
Apr 24, 2024 13:56 JST

NEC Develops High-speed Generative AI Large Language Models (LLM) with World-class Performance
Apr 24, 2024 13:25 JST

Fujitsu SX Survey reveals key success factors for sustainability
Apr 23, 2024 10:25 JST

Fujitsu and METRON collaborate to drive ESG success: slashing energy costs, boosting productivity with new manufacturing industry solutions
Apr 22, 2024 16:09 JST

NEC Strengthens Commitment to Space Industry with Investment in Seraphim Space Venture Fund II
Apr 22, 2024 15:09 JST

Soft Space Launches the First and Only JCB Payment Gateway in Malaysia
Apr 22, 2024 15:00 JST

TOYOTA GAZOO Racing takes a one-two in Croatian thriller
Apr 22, 2024 10:47 JST

First-ever Mazda CX-80 Crossover SUV Unveiled in Europe
Apr 19, 2024 13:50 JST

Fujitsu develops technology to convert corporate digital identity credentials, enabling participation of non-European companies in European data spaces
Apr 19, 2024 10:17 JST

Mitsubishi Heavy Industries and NGK to Jointly Develop Hydrogen Purification System from Ammonia Cracking Gas
Apr 18, 2024 17:01 JST

Toyota Launches All-New Land Cruiser "250" Series in Japan
Apr 18, 2024 13:39 JST

Fujitsu and Oracle collaborate to deliver sovereign cloud and AI capabilities in Japan
Apr 18, 2024 11:14 JST
 More Latest Release >>